The Anti-C1Q Ab, IgG (RDL) test measures the levels of IgG antibodies against C1q in a patient's blood.
What is C1q?
C1q is a protein that plays a crucial role in the complement system, which is a part of the immune system responsible for recognizing and clearing pathogens and damaged cells from the body.
Patients with suspected autoimmune conditions, particularly lupus nephritis, may undergo this test as part of their diagnostic workup.
Systemic lupus erythematosus (SLE) is an autoimmune disease with multiorgan involvement. Approximately 37-45% of patients with SLE will develop lupus nephritis, which negatively impacts patient survival. Testing for C1q antibodies assists in evaluating the risk of lupus nephritis development.
Limitations:
- Not all patients with lupus nephritis will be positive for C1q antibodies
- The presence of C1q antibodies is not specific for SLE
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.